Industry progress report on neuro-oncology: Biotech update 2013.
J Neurooncol
; 115(2): 311-6, 2013 Nov.
Article
em En
| MEDLINE
| ID: mdl-23949146
ABSTRACT
For the second time, The Brain Tumor Center of the Weill Cornell Brain and Spine Center, in collaboration with Voices Against Brain Cancer, hosted The Brain Tumor Biotech Summit in New York City in June 2013. After a very successful first summit in 2012, this innovative event has established a platform for intensive networking between neuro-oncologists, neurosurgeons, neuroscientists, members of the biotechnology and pharmaceutical communities, members of the financial community and leaders of non-profit organizations. This year's summit highlighted dendritic cell vaccines, novel antibody, heat shock protein and targeted therapies as well as exosome technologies, MRI-guided therapies and other novel drug delivery tools. This report presents a short overview of the current progress in brain tumor research and therapy as presented at the 2013 Brain Tumor Biotech Summit.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Biotecnologia
/
Neoplasias Encefálicas
/
Preparações Farmacêuticas
/
Indústria Farmacêutica
/
Terapia de Alvo Molecular
/
Relatório de Pesquisa
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
Revista:
J Neurooncol
Ano de publicação:
2013
Tipo de documento:
Article